Q/C Technologies, Inc. Increase (Decrease) in Deferred Compensation
Q/C Technologies, Inc. (QCLS) reported Increase (Decrease) in Deferred Compensation of -$100.54 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2026-04-15
- Q/C Technologies, Inc. increase (decrease) in deferred compensation for the quarter ending 2024-12-31 was $0.00.
- Q/C Technologies, Inc. increase (decrease) in deferred compensation for the quarter ending 2024-09-30 was -$331.99K.
- Q/C Technologies, Inc. increase (decrease) in deferred compensation for the quarter ending 2024-06-30 was $52.38K.
- Q/C Technologies, Inc. increase (decrease) in deferred compensation for the quarter ending 2024-03-31 was $179.08K.
- Q/C Technologies, Inc. increase (decrease) in deferred compensation for fiscal 2024 was -$100.54K, a 200.00% decline from fiscal 2023.
- Q/C Technologies, Inc. increase (decrease) in deferred compensation for fiscal 2023 was $100.54K.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month | Increase (Decrease) in Deferred Compensation 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$331.99K derived: sum of 2 quarters · filed 2026-04-15 | -$279.62K derived: sum of 3 quarters · filed 2026-04-15 | -$100.54K 10-K · filed 2026-04-15 |
| 2024-09-30 | -$331.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$279.62K derived: sum of 2 quarters · filed 2025-11-19 | -$100.54K 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $52.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $231.45K 10-Q · filed 2025-08-19 | ||
| 2024-03-31 | $179.08K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $100.54K 10-K · filed 2025-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |